AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo (OTCPK:DSNKY) announced Wednesday that Enhertu, their jointly developed antibody-drug conjugate, reached the main goal in a Phase 3 trial in certain ...

"I wouldn't say we expected him to win by that big of a margin, but we did have a good opinion of the horse and we're hopeful that he could trial up well and possibly sell," stable rep Ben Currie told ...

It also lifted restrictions that prevented the company from offering open-label extensions to trial participants and initiating new clinical trials with LUMRYZ for additional indications. Greg Divis, ...

One of the UK’s most promising medtech start-ups, Owlstone Medical has been given a major boost by GSK’s decision to include its technology in a major clinical trial programme. Cambridge-based ...

Geneva (AFP) – Joao Almeida grabbed overall victory in the Tour de Romandie on Sunday when he finished second to Remco Evenepoel in the closing time trial in Geneva. "The goal was to win the ...

Though only 17km in length, the final time trial made for some significant moves in the top 10, not just Almeida grabbing the win, but Evenepoel's win saw him climb up to fifth overall and cap off ...

But both are back as wildcards for the 2025 Gold Coast Pro, Stephanie by way of an invite and Julian by winning the local trials event yesterday ... “I’ve had a few wins recently, but this ...

Former Richmond FOIA officer’s case against city moves forward A trial date has been scheduled for Sept. 23 in a transparency case involving the city of Richmond’s former Freedom of Information Act ...

to conduct a study to assess Ranitidine’s safety, The Economic Times reported. What is Ranitidine, and why was it so widely used? Developed in 1981 by Glaxo Holdings Ltd (now part of GlaxoSmithKline ...